Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
In the Medicine Intensive Care Unit (MICU) at Boston Children’s Hospital, our faculty conducts research that spans the spectrum from cellular to clinical. We are dedicated to pushing the leading edge of research in order to develop new technologies and novel therapies with federal founding, foundational funding and national leadership to advance the field.
The Medicine Intensive Care Unit (MICU) at Boston Children's Hospital is a lead site for a national clinical trial of glucose control in pediatric critical care patients. The purpose of the study is to determine whether or not keeping a child’s blood sugar in the normal range during their stay in the ICU will help to decrease infections and speed up the recovery process.
Michael Agus, MD, Chief of the Division of Medicine Critical Care at Boston Children’s is one of the lead investigators in this trial.
Other researchers in our unit are currently focused on:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”